These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17981718)

  • 1. The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases.
    Thielitz A; Ansorge S; Bank U; Tager M; Wrenger S; Gollnick H; Reinhold D
    Front Biosci; 2008 Jan; 13():2364-75. PubMed ID: 17981718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation.
    Thielitz A; Reinhold D; Vetter R; Bank U; Helmuth M; Hartig R; Wrenger S; Wiswedel I; Lendeckel U; Kähne T; Neubert K; Faust J; Zouboulis CC; Ansorge S; Gollnick H
    J Invest Dermatol; 2007 May; 127(5):1042-51. PubMed ID: 16778789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
    Reinhold D; Goihl A; Wrenger S; Reinhold A; Kühlmann UC; Faust J; Neubert K; Thielitz A; Brocke S; Täger M; Ansorge S; Bank U
    Clin Chem Lab Med; 2009; 47(3):268-74. PubMed ID: 19676138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions.
    Ansorge S; Bank U; Heimburg A; Helmuth M; Koch G; Tadje J; Lendeckel U; Wolke C; Neubert K; Faust J; Fuchs P; Reinhold D; Thielitz A; Täger M
    Clin Chem Lab Med; 2009; 47(3):253-61. PubMed ID: 19327105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent actions by inhibitors of DP IV and APN family enzymes on CD4+ Teff cell motility and functions.
    Biton A; Ansorge S; Bank U; Täger M; Reinhold D; Brocke S
    Immunobiology; 2011 Dec; 216(12):1295-301. PubMed ID: 21802166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
    Reinhold D; Biton A; Pieper S; Lendeckel U; Faust J; Neubert K; Bank U; Täger M; Ansorge S; Brocke S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1935-42. PubMed ID: 17161346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblasts.
    Thielitz A; Vetter RW; Schultze B; Wrenger S; Simeoni L; Ansorge S; Neubert K; Faust J; Lindenlaub P; Gollnick HP; Reinhold D
    J Invest Dermatol; 2008 Apr; 128(4):855-66. PubMed ID: 17943180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses.
    Reinhold D; Biton A; Goihl A; Pieper S; Lendeckel U; Faust J; Neubert K; Bank U; Täger M; Ansorge S; Brocke S
    Ann N Y Acad Sci; 2007 Sep; 1110():402-9. PubMed ID: 17911455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis.
    Reinhold D; Bank U; Täger M; Ansorge S; Wrenger S; Thielitz A; Lendeckel U; Faust J; Neubert K; Brocke S
    Front Biosci; 2008 Jan; 13():2356-63. PubMed ID: 17981717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of cytokine production and silica-induced lung fibrosis by inhibitors of aminopeptidase N and of dipeptidyl peptidase-IV-related proteases.
    Kühlmann UC; Chwieralski CE; van den Brule S; Röcken C; Reinhold D; Welte T; Bühling F
    Life Sci; 2009 Jan; 84(1-2):1-11. PubMed ID: 18973761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
    Bank U; Heimburg A; Helmuth M; Stefin S; Lendeckel U; Reinhold D; Faust J; Fuchs P; Sens B; Neubert K; Täger M; Ansorge S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1925-34. PubMed ID: 17161345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells.
    Reinhold D; Bank U; Bühling F; Lendeckel U; Faust J; Neubert K; Ansorge S
    Immunology; 1997 Jul; 91(3):354-60. PubMed ID: 9301523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clones.
    Reinhold D; Hemmer B; Gran B; Born I; Faust J; Neubert K; McFarland HF; Martin R; Ansorge S
    J Neuroimmunol; 1998 Jul; 87(1-2):203-9. PubMed ID: 9670864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemia.
    Röhnert P; Schmidt W; Emmerlich P; Goihl A; Wrenger S; Bank U; Nordhoff K; Täger M; Ansorge S; Reinhold D; Striggow F
    J Neuroinflammation; 2012 Feb; 9():44. PubMed ID: 22373413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA synthesis in cultured human keratinocytes and HaCaT keratinocytes is reduced by specific inhibition of dipeptidyl peptidase IV (CD26) enzymatic activity.
    Vetter R; Reinhold D; Bühling F; Lendeckel U; Born I; Faust J; Neubert K; Ansorge S; Gollnick H
    Adv Exp Med Biol; 2000; 477():167-71. PubMed ID: 10849744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipeptidyl peptidase IV (DP IV, CD26) is involved in regulation of DNA synthesis in human keratinocytes.
    Reinhold D; Vetter RW; Mnich K; Bühling F; Lendeckel U; Born I; Faust J; Neubert K; Gollnick H; Ansorge S
    FEBS Lett; 1998 May; 428(1-2):100-4. PubMed ID: 9645485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo.
    Steinbrecher A; Reinhold D; Quigley L; Gado A; Tresser N; Izikson L; Born I; Faust J; Neubert K; Martin R; Ansorge S; Brocke S
    J Immunol; 2001 Feb; 166(3):2041-8. PubMed ID: 11160254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) induces secretion of transforming growth factor-beta 1 (TGF-beta 1) in stimulated mouse splenocytes and thymocytes.
    Reinhold D; Bank U; Bühling F; Täger M; Born I; Faust J; Neubert K; Ansorge S
    Immunol Lett; 1997 Jun; 58(1):29-35. PubMed ID: 9436466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl peptidase IV (CD26): role in T cell activation and autoimmune disease.
    Reinhold D; Hemmer B; Gran B; Steinbrecher A; Brocke S; Kähne T; Wrenger S; Born I; Faust J; Neubert K; Martin R; Ansorge S
    Adv Exp Med Biol; 2000; 477():155-60. PubMed ID: 10849742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators.
    Kehlen A; Göhring B; Langner J; Riemann D
    Clin Exp Immunol; 1998 Feb; 111(2):435-41. PubMed ID: 9486416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.